Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-22-023149

Options or other derivatives

  • Director acquired 55,090 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bjork Elisabeth · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2022-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +47,745 $10.77 2032-06-13 47,745 47,745 D
2022-06-13 Grant or award : show line 2 in the form Stock Option (Right to Buy) +7,345 $6.80 $49,946 $10.77 2032-06-13 7,345 7,345 D
Loading xslF345X03/form4.xml…